Übersetzung für "Registration statement" in Deutsch

The SEC declared the registration statement effective on July 27, 2012.

Once filed, a copy of the registration statement will be available on EDGAR at www.sec.gov .

The registration statement remains subject to review by the SEC staff.

The Registration Statement has been filed with the SEC but has not yet become effective.

These securities may not be sold nor may offers to buy be accepted prior to the time that the registration statement becomes effective.

The Registration Statement has been filed with the SEC, but has not yet become effective.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on November 7, 2017.

This information has been gathered from the company's offering prospectus. Please review the S-1 Registration Statement.

Where, since the date of incorporation or establishment, an issuer has not commenced operations and no financial statements have been made up as at the date of the registration document, a statement to that effect shall be provided in the registration document.

Where, since the date of incorporation or establishment, a collective investment undertaking has not commenced operations and no financial statements have been made up as at the date of the registration document, a statement to that effect.

Registration statement under the Securities Act of 1933 by Oiltanking Partners, L.P., stored on the NASDAQ website (Retrieved April 13, 2016).

Among the factors that may result in differences are that MorphoSys's expectations regarding a lawsuit against Janssen Biotech and Genmab, A/S, a ruling of invalidity of certain U.S. patents in a summary judgement and the right of MorphoSys to appeal this judgement to the Federal Circuit as well as expectations regarding the patent protection for MorphoSys's own CD38 antibody MOR202 and MorphoSys's ability to develop MOR202 in various indications are incorrect, the inherent uncertainties associated with competitive developments, clinical trial and product development activeties and regulatory approval requirements, MorphoSys' reliance on collaborations with third parties and other risks as indicated in the risk factors included in MorphoSys's Registration Statement on Form F-1 and other filings with the US Securities and Exchange Commission.

The securities described above will be issued pursuant to a shelf registration statement (File No. 333-222332) that was previously filed with, and declared effective by, the Securities and Exchange Commission ("SEC").

The offering was made by means of a written prospectus and prospectus supplement that form a part of the registration statement.

These forward-looking statements are subject to a number of uncertainties, including market conditions and general economic developments, as well as developments in our own business and the other factors described in the “Risk Factors” section of the registration statement of Infineon on Form F-3 filed with the U.S. Securities and Exchange Commission on July 16, 2009.

Among the factors that may result in differences are that MorphoSys's expectations may be incorrect, the inherent uncertainties associated with competitive developments, clinical trial and product development activities and regulatory approval requirements (including that MorphoSys may fail to obtain regulatory approval for MOR208 and that data from MorphoSys's ongoing clinical research programs may not support registration or further development of its product candidates due to safety, efficacy or other reasons), MorphoSys's reliance on collaborations with third parties, estimating the commercial potential of its development programs and other risks indicated in the risk factors included in MorphoSys's Registration Statement on Form F-1 and other filings with the U.S. Securities and Exchange Commission.

If you have reached this website and are in the United States of America, you should read the prospectus in that registration statement, the supplement to that prospectus Deutsche Bank expects to file with the SEC and other documents Deutsche Bank has filed and will file with the SEC before you invest.